Neoadjuvant Chemotherapy in Bladder Cancer;Neoadjuvante Chemotherapie bei Blasenkarzinomen

Strahlentherapie und Onkologie

Volumn 180, Issue 3, 2004, Pages 184-

  Dunst, Jürgen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOSTATIC AGENT; METHOTREXATE;

BLADDER CARCINOMA; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; HUMAN; NOTE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

EID: 1542289183     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Advanced Bladder Cancer Meta-Analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 2003;361:1927-34.
2. Coppin CM, Gospodarowisz MK, James K, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996;14:2901-7.
3. Stadler WM, Lerner SP. Perioperative chemotherapy in locally advanced bladder cancer. Lancet 2003;361:1922-3.